Skip to content

    Recently Viewed

      Listening...

      Johnson & Johnson to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

      Share Article
      share to

      New Brunswick, N.J., December 7th, 2023 Johnson & Johnson (NYSE: JNJ) will participate in the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8th, at the Westin St. Francis in San Francisco, CA. Joaquin Duato, Chairman and Chief Executive Officer will represent the Company in a session scheduled at 12:45 p.m. (Eastern Time)

      This live audio webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

      The audio webcast replay will be available approximately 48-hrs after the webcast.

      Media contact:
      media-relations@its.jnj.com

      Investor contact:
      investor-relations@its.jnj.com

      You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.